FMC vs IKT · rev $1.63B vs $215.2M cap
FMC Corporation (FMC) versus Inhibikase Therapeutics Inc (IKT) — a side-by-side from cached financials, not a winner call.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Inhibikase Therapeutics Inc (IKT) is a biotechnology company listed on US.
Latest reported FMC revenue for 2026-06-30 was $1.63B. Net income was -$467.9M. FMC currently screens at market cap $1.50B.
Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$36.0M. IKT currently screens at market cap $215.2M.
FMC currently screens at market cap $1.50B. IKT currently screens at market cap $215.2M.
Not investment advice. Open the FMC and IKT stock pages for the full models.
Not investment advice.